Patents by Inventor David Margel

David Margel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • URINARY BIOMARKERS FOR CANCER DIAGNOSIS
    Publication number: 20140323355
    Abstract: The present invention is directed to the field of cancer diagnosis, specifically to the diagnosis of bladder cancer (BC) and prostate cancer (CaP). More specifically, the invention provides simple, non-invasive urinary tests characterized by high sensitivity and specificity, wherein urinary levels of heat shock proteins and anti-inflammatory cytokines are used as biomarkers.
    Type: Application
    Filed: April 30, 2014
    Publication date: October 30, 2014
    Applicants: YEDA RESEARCH AND DEVELOPMENT CO. LTD., MOR - RESEARCH APPLICATIONS LTD.
    Inventors: Irun R. COHEN, Meirav PEVSNER-FISCHER, David MARGEL, Jack BANIEL, Ofer YOSSEPOWITCH
  • Urinary biomarkers for cancer diagnosis
    Patent number: 8748118
    Abstract: The present invention is directed to the field of cancer diagnosis, specifically to the diagnosis of bladder cancer (BC) and prostate cancer (CaP). More specifically, the invention provides simple, non-invasive urinary tests characterized by high sensitivity and specificity, wherein urinary levels of heat shock proteins and anti-inflammatory cytokines are used as biomarkers.
    Type: Grant
    Filed: August 3, 2010
    Date of Patent: June 10, 2014
    Assignees: Yeda Research and Development Co. Ltd., Mor—Research Applications Ltd.
    Inventors: Irun R. Cohen, Meirav Pevsner-Fischer, David Margel, Jack Baniel, Ofer Yossepowitch
  • URINARY BIOMARKERS FOR CANCER DIAGNOSIS
    Publication number: 20120149043
    Abstract: The present invention is directed to the field of cancer diagnosis, specifically to the diagnosis of bladder cancer (BC) and prostate cancer (CaP). More specifically, the invention provides simple, non-invasive urinary tests characterized by high sensitivity and specificity, wherein urinary levels of heat shock proteins and anti-inflammatory cytokines are used as biomarkers.
    Type: Application
    Filed: August 3, 2010
    Publication date: June 14, 2012
    Applicants: MOR - RESEARCH APPLICATIONS LTD., YEDA RESEARCH AND DEVELOPMENT CO. LTD.
    Inventors: Irun R. Cohen, Meirav Pevsner-Fischer, David Margel, Jack Baniel, Ofer Yossepowitch